PeptiSleep™ improves getting to sleep and quality of sleep in adults with sleep impairment
In a randomized, placebo-controlled pilot study, PeptiSleep™, a rice protein hydrolysate, showed nominally significant improvements in getting to sleep (p=0.050) and quality of sleep (p=0.036) as measured by the Leeds Sleep Evaluation Questionnaire. The study was exploratory with a small sample size (n=26) and no adjustments for multiple comparisons.
Evidence Score
Study Evidence
Study 1. Effects of PeptiSleep™ on sleep modification and biometrics in adults with sleep impairment: A randomised, placebo-controlled pilot study.
observationalMohan NM, Keogh B, Adelfio A, Maldonado R, Rao A, Altini M, Khaldi N, Franklyn-Miller A · Sleep medicine: X (2026)
Result:
Mechanism Graph
Limitations
- ⚠Small sample size (n=26) and pilot/exploratory design
- ⚠Single-blinded, no adjustments for multiple comparisons on secondary endpoints
- ⚠Objective biometrics were exploratory and not statistically significant
Frequently Asked Questions
What is PeptiSleep™?▼
PeptiSleep™ is a rice protein hydrolysate, a natural compound identified using artificial intelligence and peptide science, designed to improve sleep quality.
How effective is PeptiSleep™ for sleep?▼
In this pilot study, it showed nominally significant improvements in getting to sleep (p=0.050) and quality of sleep (p=0.036) compared to placebo, but results are exploratory and need confirmation in larger trials.
Who was studied in this trial?▼
The study included 26 adults aged 18-65 with self-reported sleep impairment, who were followed for 56 days.
Are there any side effects or safety concerns?▼
The abstract does not report side effects, but the study was small and short-term; more research is needed to establish safety.
Products
Affiliate links coming soon. We only recommend products that match the doses and forms used in the cited research.
References
- 1.Mohan NM, Keogh B, Adelfio A, Maldonado R, Rao A, Altini M, Khaldi N, Franklyn-Miller A. "Effects of PeptiSleep™ on sleep modification and biometrics in adults with sleep impairment: A randomised, placebo-controlled pilot study.." Sleep medicine: X, 2026. PMID: 42591960 DOI: 10.1016/j.sleepx.2026.100198